LRRC32, located in human chromosomal 11q13-14, has frequently been found to be amplified in tumor tissue, and its overexpression was found to promote Foxp3+ regulatory T cell activity, which in turn contributed to enhancing cancer progression and metastasis (28). Here, FOXP3 is linked to neoplasm.